ポイントオブケア凝固検査装置市場-世界の産業規模、動向、機会、予測、装置タイプ別、製品別、エンドユーザー別、地域別、競合別、2020年～2030年

ポイントオブケア凝固検査装置の世界市場規模は2024年に18億4,000万米ドルとなり、2030年までには25億8,000万米ドルに達し、予測期間中のCAGRは5.79%で成長すると予測されています。

この市場は、深部静脈血栓症（DVT）、肺塞栓症、心筋梗塞、血友病、von Willebrand病などの血栓性疾患や出血性疾患の有病率の増加により、強い勢いを見せています。

高齢化や生活習慣に関連する要因によってますます一般的になっているこれらの疾患では、特に抗凝固療法を長期間受けている患者において、頻繁かつタイムリーな凝固モニタリングが求められています。救急治療室、外科手術室、抗凝固クリニック、在宅ヘルスケアにおける迅速な診断の必要性が、数分で正確な結果を得ることができるPOC（ポイントオブケア）凝固検査装置への需要を高めています。

この市場を牽引する顕著な動向は、ヘルスケア業界における分散型診断へのシフトであり、従来の集中型ラボ検査よりもポータブルで使いやすい機器が支持されています。この変革により、臨床的意思決定が強化され、手続きの遅れが最小限に抑えられ、さまざまな医療環境で患者ケアが改善されつつあります。

主要な市場促進要因

心血管・止血障害の有病率の上昇

主要な市場課題

デバイスと消耗品の高コスト

主要な市場動向

デジタル接続と遠隔医療ソリューションの統合

これらの装置と組み合わせたスマートフォンアプリは以下を提供します：

• 検査手順のガイド
• 検査結果の視覚的表示
• 傾向分析
• リアルタイムの警告と通知

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のポイントオブケア凝固検査装置市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 装置タイプ別（抗凝固モニタリング機器、血小板機能モニタリング機器、粘弾性凝固モニタリング機器、その他）
  • 製品別（機器/分析装置、消耗品・アクセサリ）
  • エンドユーザー別（病院、診療所、在宅ケア施設、その他）
  • 企業別（2024年）
  • 地域別
• 市場マップ

第6章 北米のポイントオブケア凝固検査装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州のポイントオブケア凝固検査装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋のポイントオブケア凝固検査装置市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米のポイントオブケア凝固検査装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのポイントオブケア凝固検査装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Werfen, S.A.
• Siemens Healthineers
• Helena Laboratories Corporation
• Medtronic plc
• Koninklijke Philips N.V.
• Alere Inc.
• HemoSonics, LLC
• Sysmex Corporation

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Point of Care Coagulation Testing Devices Market was valued at USD 1.84 Billion in 2024 and is projected to reach USD 2.58 Billion by 2030, growing at a CAGR of 5.79% during the forecast period. This market is experiencing strong momentum, driven by the growing prevalence of thrombotic and bleeding disorders such as deep vein thrombosis (DVT), pulmonary embolism, myocardial infarction, hemophilia, and von Willebrand disease.

These conditions, increasingly common due to aging populations and lifestyle-related factors, demand frequent and timely coagulation monitoring-especially among patients undergoing long-term anticoagulant therapies. The need for rapid diagnostics in emergency rooms, surgical units, anticoagulation clinics, and home healthcare is fueling demand for point of care (POC) coagulation devices that deliver accurate results in minutes.

A notable trend driving this market is the healthcare industry's shift toward decentralized diagnostics, favoring portable, easy-to-use devices over traditional, centralized lab testing. This transformation is enhancing clinical decision-making, minimizing procedural delays, and improving patient care across a variety of care settings.

Key Market Drivers

Rising Prevalence of Cardiovascular and Hemostatic Disorders

The rising burden of cardiovascular diseases (CVDs) and hemostatic disorders is a primary growth catalyst. According to the World Health Organization, CVDs are responsible for approximately 17.9 million deaths annually, accounting for 32% of all global fatalities. One-third of these occur prematurely, before the age of 70.

In the United States alone, CVDs caused 930,000 deaths in 2020, making them the leading cause of mortality. Similarly, 2.2 million deaths across the Americas in 2021 were attributed to cardiovascular conditions. Despite a decline in mortality rates over recent decades, the absolute number of cases remains high, driven by aging populations and lifestyle-related risk factors.

Key Market Challenges

High Cost of Devices and Consumables

One of the most significant barriers to market growth is the high cost associated with POC coagulation testing systems. These devices often involve substantial upfront capital investment, particularly when equipped with wireless connectivity, data integration tools, and automated features.

Recurring expenses on test cartridges, reagents, maintenance, and software updates further strain hospital and clinic budgets-particularly in low-resource settings and developing regions. For home users, the cost of consumables over time can lead to reduced testing frequency or non-compliance, which compromises treatment safety and outcomes.

In public healthcare systems where budgets are constrained, procurement decisions often prioritize cost over long-term clinical value. Reimbursement inconsistencies further discourage adoption of these technologies in outpatient and remote care environments. Additionally, premium-priced consumables for advanced coagulation tests such as TEG and ROTEM are often limited to larger, better-funded hospitals.

Key Market Trends

Integration of Digital Connectivity and Telehealth Solutions

One of the most transformative trends reshaping this market is the digital evolution of POC coagulation devices. Modern analyzers now feature Bluetooth and Wi-Fi capabilities, allowing for instant transmission of results to electronic health record (EHR) systems or secure cloud platforms.

This connectivity enables remote patient monitoring, particularly for individuals on anticoagulants such as warfarin or DOACs. Physicians can monitor INR/PT levels in real time, adjust dosages, and enhance treatment compliance-all without in-person visits.

Smartphone apps paired with these devices offer:

• Guided test procedures
• Visual display of results
• Trend analysis
• Real-time alerts and notifications

This ecosystem supports telehealth platforms, enabling virtual consultations and improving access in rural or home-based settings. Remote diagnostics, firmware updates, and device troubleshooting via apps are also streamlining usability and reducing support burdens.

Key Market Players

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Werfen, S.A.
• Siemens Healthineers
• Helena Laboratories Corporation
• Medtronic plc
• Koninklijke Philips N.V.
• Alere Inc.
• HemoSonics, LLC
• Sysmex Corporation

Market Segmentation

By Device Type:

• Anticoagulation Monitoring Devices
• Platelet Function Monitoring Devices
• Viscoelastic Coagulation Monitoring Devices
• Others

By Product:

• Instruments/Analyzers
• Consumables & Accessories

By End User:

• Hospitals
• Clinics
• Home Care Settings
• Others

By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

The report provides detailed profiles and strategic insights for leading companies operating in the Global Point of Care Coagulation Testing Devices Market. Analysis includes product innovation, market positioning, technological advancements, and global footprint.

Available Customizations

TechSci Research offers customizable elements in this report to align with specific business needs. Available options include:

• In-depth analysis and profiling of up to five additional market players

Let me know if you'd like this version adapted into a presentation deck, executive summary, or slide notes for a meeting!

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Point of Care Coagulation Testing Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device Type (Anticoagulation Monitoring Devices, Platelet Function Monitoring Devices, Viscoelastic Coagulation Monitoring Devices, Others)
  • 5.2.2. By Product (Instruments/Analyzers, Consumables & Accessories)
  • 5.2.3. By End User (Hospitals, Clinics, Home Care Settings, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Point of Care Coagulation Testing Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device Type
  • 6.2.2. By Product
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Point of Care Coagulation Testing Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Point of Care Coagulation Testing Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Point of Care Coagulation Testing Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By End User

7. Europe Point of Care Coagulation Testing Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device Type
  • 7.2.2. By Product
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By End User

8. Asia-Pacific Point of Care Coagulation Testing Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device Type
  • 8.2.2. By Product
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By End User
  • 8.3.2. India Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By End User

9. South America Point of Care Coagulation Testing Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device Type
  • 9.2.2. By Product
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Point of Care Coagulation Testing Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Point of Care Coagulation Testing Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Point of Care Coagulation Testing Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By End User

10. Middle East and Africa Point of Care Coagulation Testing Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device Type
  • 10.2.2. By Product
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Point of Care Coagulation Testing Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Point of Care Coagulation Testing Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Point of Care Coagulation Testing Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. F. Hoffmann-La Roche Ltd.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Abbott Laboratories
• 15.3. Werfen, S.A.
• 15.4. Siemens Healthineers
• 15.5. Helena Laboratories Corporation
• 15.6. Medtronic plc
• 15.7. Koninklijke Philips N.V.
• 15.8. Alere Inc.
• 15.9. HemoSonics, LLC
• 15.10. Sysmex Corporation

16. Strategic Recommendations

17. About Us & Disclaimer